13 Feb 2003, 06:03 PM EST
FOR IMMEDIATE RELEASE
LifePoint, Inc. Changes the Date of
Its Third Quarter Fiscal 2003 Conference Call
ONTARIO, CA, February 13, 2003 – LifePoint, Inc. (AMEX: LFP), announced that due to the
fact that its auditors have not completed their review of the quarter ended December 31, 2002 the
conference call has been rescheduled for Thursday, February 20, 2003 at 9:00 a.m., EST (6:00
a.m. PST), with Linda H. Masterson, President and CEO, and Michele Clark, Controller and
Chief Accounting Officer.
What: LifePoint, Inc.’s Fiscal 2003 Third Quarter Conference Call
When: Thursday, February 20, 2003, 9:00 a.m. EST
Web address: www.streetevents.com, www.companyboardroom.com, or
www.LifePointInc.com
Dial-in numbers: 1-800-915-4836 (domestic) and 1-973-317-5319 (international)
Contact: Lester Rosenkrantz, Cameron Associates, 212-245-8800 x212
If you are unable to participate, an audio digital replay of the call will be available from
Thursday, February 20th at 11 a.m. EST until Midnight EST on February 27th by dialing 1-800-
428-6051 (domestic) or 973-709-2089 (international) using confirmation code #286161. A web
archive will be available for 30 days at www.streetevents.com, www.companyboardroom.com ,
or www.LifePointInc.com. The company will issue its quarterly letter to shareholders following
the conference call.
About LifePoint, Inc.
LifePoint, Inc., a leader in non-invasive drug diagnostic technologies and solutions, has
developed, manufactures and markets the IMPACT Test System – a rapid diagnostic testing,
screening and drug monitoring device for use in the workplace, home health care, ambulances,
pharmacies and law enforcement. LifePoint’s patented and proprietary technologies for the use of
saliva as a non-invasive, blood-comparable test specimen, used in conjunction with the flow
immunosensor technology licensed from the United States Navy, has allowed LifePoint to
develop a broadly applicable, rapid, on-site diagnostic test system. The first product
simultaneously detects drugs of abuse and alcohol, with the initial three target markets estimated
to be over $1.6 billion.
LifePoint® and IMPACT® are trademarks of LifePoint, Inc.
Chris
